Preview Mode Links will not work in preview mode

The On-Air Advocate

Dec 30, 2021

As we continue our Cholangiocarcinoma Series I am excited to welcome, Peter Langmuir, M.D., Group Vice President, Oncology Targeted Therapies, Incyte. 

Peter Langmuir, M.D. is Group Vice President of Oncology Targeted Therapeutics at Incyte. 

Dr. Langmuir earned his medical degree at the Yale University School of Medicine and trained in pediatrics and pediatric hematology-oncology at The Children’s Hospital of Philadelphia. 

He has worked in the pharmaceutical and biotech industry for the past 18 years, focusing primarily on the clinical development of targeted therapies for both solid tumors and hematologic malignancies.

Listen in as Peter shares about the collaboration between Incyte and the Cholangiocarcinoma Foundation with drug development & patient advisory boards. 

Learn More About Cholangiocarcinoma At:

Visit for information on all of our products, services & resources.